Skip to content

Taco Kuijpers

Principal Investigator

Emma Research

For the latest publications of this PI visit Taco Kuijpers – Amsterdam UMC
Kuijpers, T.W. (Taco) t.w.kuijpers@amsterdamumc.nl

Research linePediatric Immunology
DepartmentPediatric Infectious Diseases, Rheumatology and Immunology
Research Institute(s)Amsterdam institute for Immunology & Infectious diseases
DescriptionThis research line aims to determine the impact of immune dysfunction in genetically determined so-called “inborn errors of immunity (IEIs)” and various conditions of induced (acquired) innate or adaptive immune dysregulation. To these conditions, (auto)inflammatory and B-cell immune-mediated disorders (B-IMDs) are being focused on.
In the realm of infection and inflammatory diseases in children we try to find an RNA- and/or protein-based signature to distinguish large categories of disease as a “super-CRP” in a large European consortium to categories to guide diagnostics and treatment in a faster and more certain fashion.

Seniors• Taco Kuijpers, PI
• Helin Tercan (Sanquin) en Celine Mahieu (Sanquin), postdocs
Giske Biesbroek (AMC), clinical fellow ped rheumatology, coordinator DIAMONDS study
Projects
NK CAR cells for cancer treatment: functionality and production.NK CAR cells for cancer treatment: functionality and production.
T2B-iCAREThis study investigates when to apply novel immune therapies – including CART - in B-cell immune-mediated disorders
BTHS iPSC neutrophil developmentBTHS iPSC neutrophil development
Neutrophil extracellular trap formation (NETs): mechanisms of actionNeutrophil extracellular trap formation (NETs): mechanisms of action
Role of neutrophil activation and cell death by NET formation in TRALIRole of neutrophil activation and cell death by NET formation in TRALI
Autoimmune disease: imbalances with a signature (Immune Health Seed)Autoimmune disease: imbalances with a signature (Immune Health Seed)
Inborn errors of immunity: molecular mechanisms, NFkB activation and interferonopathies.Inborn errors of immunity: molecular mechanisms, NFkB activation and interferonopathies.
Kawasaki DiseaseKawasaki Disease
DIAMONDS

Last edited: 05-03-2026